AKT1 and small cell lung carcinoma: Specifically in SCLC, kinases are aberrantly expressed in signaling pathways, such as PI3K (phosphoinositide 3-kinase)–AKT–mTOR (mammalian target of rapamycin), which aids in SCLC cell survival and chemotherapy resistance [15].